Optimising the trade-off between type I and II error rates in the Bayesian context. | Pharm Stat;20(4): 710-720, 2021 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Optimising the trade-off between type I and II error rates in the Bayesian context.

Walley, Rosalind J; Grieve, Andrew P.

Affiliation

Walley RJ; Statistical Sciences and Innovation, UCB Pharma, Slough, UK.
Grieve AP; Statistical Sciences and Innovation, UCB Pharma, Slough, UK.

Pharm Stat ; 20(4): 710-720, 2021 07.

Article in En | MEDLINE | ID: mdl-33619884

Subject(s)
Key words

Bayesian; decision criteria; design prior; pre-posterior distribution; trial design; type I error

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: